Home -> Law Blog Directory -> Personal Injury Law Blogs -> Chicago Injury Attorney Blog
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Personal Injury Law
: Chicago Injury Attorney BlogDangerous Drug?: Avandia a Heart Attack Risk and GlaxoSmithKline Knew, Says Senate Report
According to a senate report released today, pharmaceutical drug manufacturer GlaxoSmithKline knew that that Avandia was causing about 500 heart attacks a month yet failed to pull the drug off the market despite the US Food and Drug Administration?s recommendation that the company do so 2008. 304 fatalities were linked to this medication during 2009?s third quarter. The diabetes drug is still available for use to this day, and hundreds of thousands of people continue to take it.
The report claims that the drug manufacturer has known for years about the heart attack risk created by taking Avandia and asked doctors not to warn about this possible side effect. The diabetes drug, which has been available since 1999, made $3 billion in 2006. Sales went down to $1.2 billion last year after the New England Journal of Medicine published a study reporting that people who take Avandia may increase their heart attack risk by 43%.
In 2008, FDA officials found that not only did Avandia increase a user?s heart attack risk, but it wasn?t any more effective than rival drug Actos. In 2007, the Journal of the American Medical Association published a study that concluded that use of Avandia increased heart failure risk by 60%, heart attack risk by 40%, and one?s fatality risk by 29%.
Avandia is usually prescribed to people suffering from Type 2 diabetes. The New York Times says that if all Avandia users were given Actos instead, about 300 heart failure cases and 500 heart attacks would be avoided each month. Meantime, Glaxo denies that Avandia is a heart risk.
Dangerous Drugs
Our Chicago, Illinois products liability lawyers represent clients who were injured, became sick, or died from a dangerous pharmaceutical drug. Drug manufacturers are supposed to make products that are safe for people to take. You may have grounds for filing a dangerous drug lawsuit if a pharmaceutical company makes a dangerous drug, fails to warn of certain side effects, or tries to conceal the risks associated with the medication.
Glaxo Knew Avandia Caused Heart Risk, Report Says (Update1), BusinessWeek, February 20, 2010
Research Ties Diabetes Drug to Heart Woes, New York Times, February 19, 2010
Related Web Resources:
Avandia Press Kit, GSK
Type 2 Diabetes, American Diabetes Association
US Food and Drug Administration
Full post as published by Chicago Injury Attorney Blog on February 21, 2010 (boomark / email).
Mitchell Report Summary
Report on Steroid Drug Use in Major League Baseball by Senator George Mitchell
Bextra Product Recall
Find a Bextra Lawyer
Bextra Injury Risks
Bextra Increases Risk of Fatal Heart Attack
Paxil Lawsuit
Paxil Claims, Lawsuits, and Injuries
Heart of Atlanta v United States
Supreme Court Decision: Civil Rights Act Protected by Interstate Commerce Clause
Truth In Lending Act
Consumer Loans and Consumer Credit Protection Act
Avandia
alleging heart attacks, increased fracture risk that may have been caused by Avandia.
Smokeless Tobacco Increases Risk of Stroke and Heart Attack
Smokeless Tobacco Increases Risk of Stroke and Heart Attack
Vytorin
alleged risk of heart attack and liver damage.
Ezetrol, Canada
allegedly can cause heart attack or stroke in patients using it.
Ortho Evra Contraceptive Patch
allegedly causing fatal blood clots, heart attack, and stroke.
Digitek Recalled
the heart drug allegedly contains double the medication that it should

Avandia Heart Attack: Questions Still Remain
Avandia Decline Not Affecting GlaxoSmithKline
Avandia Hanging Around Like a Bad Smell
Family hits GlaxoSmithKline with Avandia wrongful death lawsuit
Avandia Maker Cited by the FDA
Dangerous Drug Lawsuit: Man Claims Diabetes Drug Avandia Caused Heart Attack








